Dr. Steven David Kavy, MD

Dr. Kavy practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Kavy's NPI, 1285646802, was assigned on August 12, 2006. Dr. Kavy graduated from SUNY Downstate Health Sciences University in 1984. Dr. Kavy holds California license G61658.

Dr. Kavy's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Kavy's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. Dr. Kavy is also affiliated with Sharp Memorial Hospital. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Kavy to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kavy practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Kavy's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Kavy is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kavy's licenses on file in 2 states: California and Georgia.

Dmand AI lists asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), hypersomnia, pleural effusion, pneumonia and pulmonary fibrosis among the conditions Dr. Kavy treats.

CMS data shows 1,044 Medicare services from Dr. Kavy across 12 procedure codes in 2024, for 562 Medicare patients. Medicare paid $83,977 for them.

CMS counts 562 Medicare patients who saw Dr. Kavy in 2024. The largest group is 65 to 74, with 291 patients. 71% of them have high blood pressure, and 71% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kavy's median patient age at 69, with 45% women.

In 2024, Dr. Kavy wrote 693 Medicare Part D claims for 122 patients. 67% of them were for generic drugs. CMS names the drug for 510 of them, across 17 drugs with 11 or more claims each, at $552,860 in total drug cost. In 2023, CMS named 707 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Kavy for performance year 2024, reported as part of a group. Dr. Kavy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kavy as offering telehealth.

CMS Open Payments shows 31 general payments to Dr. Kavy from 11 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 94% of the total. LivaNova USA, Inc. paid the most, $17,848. It also lists 1 research payment totaling $750 in 2021.

Dmand AI lists 4 awards for Dr. Kavy, most recently San Diego Top Doctor in 2021.

Dr. Kavy graduated from SUNY Downstate Health Sciences University in 1984.

Dr. Kavy is in network with 5 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.